ArticleJournal of pharmaceutical health care and sciences2019

Retrospective cohort study of the efficacy and safety of dabigatran: real-life dabigatran use including very low-dose 75 mg twice daily administration.

Yuuki Akagi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.